Patents by Inventor Peter Hinsmann

Peter Hinsmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250009885
    Abstract: The present invention relates to an injectable pharmaceutical formulation comprising a compound of formula (I) said formulation being buffered to a pharmaceutically acceptable pH-value, especially a pH-value of from 2 to 6, in particular a pH value of from 3 to 5.5, preferred a pH-value of about 4 to 5, particularly preferred about 5.
    Type: Application
    Filed: September 20, 2024
    Publication date: January 9, 2025
    Inventors: Mathias Ferencic, Werner Heilmayer, Peter Hinsmann, Wolfgang Wicha
  • Patent number: 12121582
    Abstract: The present invention relates to an injectable pharmaceutical formulation comprising a compound of formula (I) the formulation being buffered to a pharmaceutically acceptable pH-value, especially a pH-value of from 2 to 6, in particular a pH value of from 3 to 5.5, preferred a pH-value of about 4 to 5, particularly preferred about 5.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: October 22, 2024
    Assignee: NABRIVA THERAPEUTICS GMBH
    Inventors: Mathias Ferencic, Werner Heilmayer, Peter Hinsmann, Wolfgang Wicha
  • Patent number: 10913703
    Abstract: The present invention relates to purification methods of pleuromutilin (I) by means of crystallisation and/or recrystallisation. The process according to the present invention is carried out in the presence of i-propylacetate.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: February 9, 2021
    Assignee: NABRIVA THERAPEUTICS GMBH
    Inventors: Werner Heilmayer, Lee Spence, Peter Hinsmann
  • Publication number: 20200231529
    Abstract: The present invention relates to purification methods of pleuromutilin (I) by means of crystallisation and/or recrystallisation. The process according to the present invention is carried out in the presence of i-propylacetate.
    Type: Application
    Filed: February 9, 2018
    Publication date: July 23, 2020
    Inventors: Werner HEILMAYER, Lee SPENCE, Peter HINSMANN
  • Publication number: 20180360966
    Abstract: The present invention relates to an injectable pharmaceutical formulation comprising a compound of formula (I) said formulation being buffered to a pharmaceutically acceptable pH-value, especially a pH-value of from 2 to 6, in particular a pH value of from 3 to 5.5, preferred a pH-value of about 4 to 5, particularly preferred about 5.
    Type: Application
    Filed: June 14, 2016
    Publication date: December 20, 2018
    Inventors: Mathias Ferencic, Werner Heilmayer, Peter Hinsmann, Wolfgang Wicha